BDB is advising Bioquell plc in connection with its takeover by Ecolab U.S. 2 Inc., a wholly-owned subsidiary of Ecolab Inc.. Bioquell is a UK-based leading provider of specialist hydrogen peroxide vapour bio-decontamination equipment, modular isolators and associated services for the life sciences and healthcare sectors. Ecolab is a US listed global leader in water, hygiene and energy technologies and services.
The recommended all cash offer of 590p per share, values Bioquell at approximately £140.51 million. The offer is to be effected by means of a court-sanctioned scheme of arrangement and is supported by shareholders representing 55.10% of the ordinary share capital (through irrevocable undertakings and a letter of intent).
